Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00013793 · ClinicalTrials.gov registry record · NA

Ultrasound and Motivational Enhancement for Prenatal Smoking Cessation

A NA study, sponsored by National Center for Research Resources (NCRR).

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT00013793 is a NA study that has completed, run by National Center for Research Resources (NCRR). The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00013793, a NA study, has completed, sponsored by National Center for Research Resources (NCRR).

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The primary purpose of this randomized clinical trial is to test the efficacy of motivational enhancement (ME) therapy combined with biologic feedback (fetal ultrasound) for increasing smoking quit rates among low-income pregnant women considered resistant smokers. We hypothesize that ME along with biofeedback will increase the rate of validated smoking cessation at 8 months gestation by at least 10 percentage points above that produced by "Best Practice" (BP) counseling alone. This study will also examine reduction of smoking among non-quitters and maintenance of smoking cessation through 6 weeks postpartum among women who quit. Prenatal smoking is the leading preventable cause of low birth weight in the US. Reduction in smoking during pregnancy could result in significant improvements in pregnancy outcomes and reducing the cost of health care. There is evidence that low-intensity pregnancy smoking cessation programs may be inadequate for women who are more addicted, and at educational and economic disadvantage. Motivational enhancement strategies have shown considerable promise in the treatment of addictive behaviors. Physiological feedback highlighting prenatal effects of smoking and benefits of cessation has been found to enhance prenatal smoking cessation counseling. An intervention that combines motivational enhancement counseling and physiological feedback may have powerful effects beyond low-intensity interventions or usual counseling.

Interventions

  • BEHAVIORAL Motivational enhancement and ultrasound

Trial Details

FieldValue
Enrollment Target 30 participants
Phase NA

What the Registry Record Tells You About NCT00013793

The ClinicalTrials.gov registry entry for NCT00013793 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Motivational enhancement and ultrasound is the first listed.

NCT00013793 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00013793 about?

NCT00013793 is a clinical study titled "Ultrasound and Motivational Enhancement for Prenatal Smoking Cessation". The primary purpose of this randomized clinical trial is to test the efficacy of motivational enhancement (ME) therapy combined with biologic feedback (fetal ultrasound) for increasing smoking quit rates among low-income pregnant women considered resistant smokers. We hypothesize that ME along with ...

What is the current status of trial NCT00013793?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants.

What interventions are being tested in trial NCT00013793?

The interventions under investigation include: Motivational enhancement and ultrasound (BEHAVIORAL).

Who is sponsoring clinical trial NCT00013793?

This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.